Proquin XR FDA Approval History
FDA Approved: Yes (Discontinued) (First approved May 19, 2005)
Brand name: Proquin XR
Generic name: ciprofloxacin
Dosage form: Extended-Release Tablets
Company: Depomed, Inc.
Treatment for: Urinary Tract Infection
Marketing Status: Discontinued
Proquin XR (ciprofloxacin) is an extended release fluoroquinolone antibiotic indicated for the treatment of urinary tract infections.
Development timeline for Proquin XR
|May 19, 2005||Approval Proquin XR Depomed, Inc. - Treatment for Uncomplicated Urinary Tract Infections|
|Sep 20, 2004||Depomed Announces Proquin XR NDA Accepted by FDA|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.